Biktarvy, formally known as bictegravir, represents a effective single-tablet therapy for treating HIV infection. This drug integrates three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the the viral ability to copy within the body, significantly decreasing the viral burden. For man